Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001331339-25-000005
Filing Date
2025-11-17
Accepted
2025-11-17 16:30:24
Documents
1
Period of Report
2025-11-13

Document Format Files

Seq Description Document Type Size
1 form4-11172025_041118.html 4  
1 form4-11172025_041118.xml 4 6105
  Complete submission text file 0001331339-25-000005.txt   7679
Mailing Address C/O BEJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Business Address
Powell Fred M (Reporting) CIK: 0001331339 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40241 | Film No.: 251491418

Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)